Business

Notice of 2022 Full-Year Results and Annual Report

Notice of 2022 Full-Year Results and Annual Report.

articleFaron Pharmaceuticals OyFebruary 6, 20234/company/faron-pharmaceuticals-oy/news/notice-of-2022-full-year-results-and-annual-report
Notice of 2022 Full-Year Results and Annual Report

About this update from Faron Pharmaceuticals Oy

[{"type":"text","content":"\n \n \n \n Faron Pharmaceuticals Oy\n \n \n \n (\"Faron\" or the \"Company\")\n \n \n \n  \n \n \n \n \n Notice of 2022 Full-Year Results and Annual Report\n \n \n \n \n  \n \n \n \n \n Press release, February 6, 2023 at 02:00 AM (EST) / 07:00 AM (GMT) / 09:00 AM (EET)\n \n \n \n \n  \n \n \n \n \n TURKU, FINLAND / BOSTON, MA\n \n - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on tackling difficult-to-treat cancers and inflammation via precision immunotherapy,\n  will publish its audited full-year results for the twelve months ended December 31, 2022, on Thursday, March 2, 2023, at\n \n 02:00 AM (EST) / 07:00 AM (GMT) / 09:00 AM (EET).\n \n \n The Annual Report 2022, including audited financial statements for the full year, will be published on the same day.\n \n \n \n \n  \n \n \n \n \n Dr. Markku Jalkanen, Chief Executive Officer, and Toni Hänninen, Chief Financial Officer, will host a virtual briefing and Q&A session for analysts at 7:00 AM (EST) / 12:00 PM (GMT) / 2:00 PM (EET) on the day of results.\n \n \n \n \n  \n \n \n \n The full-year results press release for 2022, presentation, virtual briefing webcast details, and Annual Report 2022 will be made available at\n \n \n www.faron.com/investors\n \n \n . A replay of the analyst briefing will be made available shortly afterwards.\n \n \n  \n \n \n For more details about the analysts' briefing, please contact\n \n \n [email protected]\n \n \n .\n \n \n  \n \n \n \n For more information please contact:\n \n \n \n \n  \n \n \n \n \n Investor Contact\n \n \n \n \n Faron Pharmaceuticals\n \n \n \n Julia Balanova\n \n \n VP, Investor Relations\n \n \n \n \n [email protected]\n \n \n \n \n \n \n [email protected]\n \n \n \n \n Phone: +1 (917) 306-6096\n \n \n \n  \n \n \n \n \n Media Contact\n \n \n \n \n Faron Pharmaceuticals\n \n \n \n Jennifer Smith-Parker\n \n \n Head of Communications\n \n \n \n \n [email protected]\n \n \n \n \n  \n \n \n \n Cairn Financial Advisers LLP, Nomad\n \n \n \n Sandy Jamieson, Jo Turner\n \n \n Phone: +44 (0) 207 213 0880\n \n \n \n  \n \n \n \n \n Peel Hunt LLP, Broker\n \n \n \n Christopher Golden, James Steel\n \n \n Phone: +44 (0) 20 7418 8900\n \n \n \n  \n \n \n \n \n S...

More updates from Faron Pharmaceuticals Oy